Search

everythinglearnresearchcommunity

for

Search:↓

Skin's Regulatory T cells are crucial for maintaining skin health and could be targeted to treat immune-related skin diseases and cancer.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Thymus transplantation successfully restored immune function in infants with FOXN1 deficiency.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

The study found that two enzymes linked to hair loss are located in different parts of the scalp, supporting a common treatment's effectiveness.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

A WNT10A gene mutation leads to ectodermal dysplasia by disrupting cell growth and differentiation.

The Wnt/β-catenin pathway helps tissue regeneration but can also cause fibrosis, and drugs that inhibit this pathway may aid in healing skin and heart tissues.

Nanoparticles can improve skin treatments by better targeting hair follicles, but more research is needed for advancement.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

Prolactin affects hair growth cycles and can cause early hair follicle regression.

Low-level laser therapy might help hair growth, but more research is needed.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

FPHL is a common, age-related, genetic hair loss with unclear causes and limited treatment options.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

The skin protects the body and is constantly renewed by stem cells; disruptions can lead to cancer.

Hair mineral analysis might help diagnose diseases early, but standard methods are needed.

The document concludes that rapid identification, isolation, and strict infection control are crucial to manage SARS outbreaks.

Treatments for melanin disorders exist, but more effective options needed.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

A girl with rickets and hair loss was found to have a rare condition where her body didn't respond to vitamin D treatment.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

Low-dose oral minoxidil and spironolactone combo effectively reduces hair loss and improves hair density in women.

A new gene, JMJD1C, may affect testosterone levels in men.

Menopause reduces skin collagen and elasticity, and while estrogen therapy can help, its risks require careful consideration.